{"id":"W1522421496","doi":"10.1016/j.ohc.2006.05.009","title":"10.1016/j.ohc.2006.05.009","year":2000,"lang":"en","type":"review","venue":"Time to knit","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":299,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Ranibizumab; Medicine; Dosing; Visual acuity; Clinical trial; Ophthalmology; Adverse effect; Stroke (engine); Regimen; Bevacizumab; Internal medicine; Chemotherapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0006184988,0.001395913,0.0007594089,0.001318189,0.001102771,0.003230026,0.001455012,0.005258689,0.9271054],"category_scores_gemma":[0.00104423,0.0003811253,0.0007092995,0.0006711797,0.000705802,0.002151982,0.001169532,0.002181076,0.8513204],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001196345,"about_ca_system_score_gemma":0.001656847,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002202219,"about_ca_topic_score_gemma":0.003038489,"domain_scores_codex":[0.9995627,0.0000437315,0.00002994181,0.0001137166,0.0001267641,0.0001232092],"domain_scores_gemma":[0.9991537,0.0001439114,0.00006884307,0.00006459824,0.0002241485,0.0003447788],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000309663,0.0004424384,0.001885548,0.0004858024,0.00004118137,0.0004273255,0.00008148984,0.0001800297,0.001186804,0.003852251,0.2750046,0.7161027],"study_design_scores_gemma":[0.00009464761,0.0001113251,0.002072861,0.0005597472,0.00002636768,0.001911375,0.0001507236,0.0001702918,0.0002742483,0.00182282,0.9927873,0.00001815242],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.00279655,0.008359292,0.001695353,0.004127513,0.001979952,0.0001439381,0.001295457,0.0008874024,0.9787146],"genre_scores_gemma":[0.005606028,0.002792296,0.001610185,0.001909899,0.0004398638,0.00007541741,0.00116193,0.000205743,0.9861987],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.07289463,"threshold_uncertainty_score":0.1039754,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02071203103106387,"score_gpt":0.2757241986666178,"score_spread":0.2550121676355539,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}